VanceFowlerMDMHS

Professor, Medicine, Duke University School of Medicine

Dr. Fowler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Elected Member The American Society for Clinical Investigation, 2007
Association of American Physicians
Best Doctors in America
Alpha Omega Alpha University of North Carolina
Rotary International Fellowship, Amani, Tanzania Rotary International
MAP/Reader's Digest International Fellowship, Mwandi, Zambia
Chair, Gordon Research Conference in Staphylococcal Diseases
Oswald Avery Award Infectious Diseases Society of America
Ruth & A. Morris Williams, Jr. Faculty Research Award Duke University Medical Center
Outstanding Investigator Award American Federation for Medical Research
Clinical Research Outstanding Achievement Award Clinical Research Forum
Young Investigator Award American Society for Microbiology
Junior Physician-Investigator Award American Federation for Medical Research
Join now to see all

PubMed

ARGONAUT-IV: susceptibility of carbapenemase-producingto the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibuten.
Michael R Jacobs, Caryn E Good, Ayman M Abdelhamed, Andrew R Mack, Christopher R Bethel
Antimicrobial Agents and Chemotherapy. 2024-12-05
Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections.
Angelique E Boutzoukas, Natalie Mackow, Abhigya Giri, Lauren Komarow, Carol Hill
The Journal of Antimicrobial Chemotherapy. 2024-11-04
A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing.
Mohamad Yasmin, Steven H Marshall, Liang Chen, Daniel D Rhoads, Michael R Jacobs
Antimicrobial Agents and Chemotherapy. 2024-10-08

Journal Articles

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcu...
Helen W Boucher, Sara E Cosgrove, G Ralph Corey, Thomas L Holland, Vance G Fowler, Clinical Infectious Diseases

Other

Epidemiology of and risk factors for Staphylococcus aureus bacteremia in children
Fowler VG, Sexton DJ, Kaplan SL
http://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-staphylococcus-aureus-bacterem
UpToDate, Wolters Kluwer Health - 2012-10-26
Complications of Staphylococcus aureus bacteremia
Fowler VG, Sexton DJ
http://www.uptodate.com/contents/complications-of-staphylococcus-aureus-bacteremia
UpToDate, Wolters Kluwer Health - 2012-10-05
Treatment of Staphylococcus aureus bacteremia in adults
Fowler VG, Sexton DJ
http://www.uptodate.com/contents/treatment-of-staphylococcus-aureus-bacteremia-in-adults
UpToDate, Wolters Kluwer Health - 2013-03-01
Epidemiology of Staphylococcus aureus bacteremia in adults
Fowler VG, Sexton DJ
http://www.uptodate.com/contents/epidemiology-of-staphylococcus-aureus-bacteremia-in-adults
UpToDate, Wolters Kluwer Health - 2012-06-15
Join now to see all

The Free Market Is Failing Us on AntibioticsDecember 25th, 2022
DARPA ECHO Program Testing Epigenome or DNA Changes for Tracking Exposure to Threat Agents, Weapons of Mass Destruction (WMD) on BattlefieldSeptember 30th, 2021
Contrafect Announces Publication of Exebacase Phase 2 Study Results in the Journal of Clinical InvestigationJune 17th, 2020
Join now to see all